4 Results for "

CRLF2r

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "CRLF2r" in MCE Product Catalog:

Cat. No.: HY-151902
CAS No.: 2595365-41-4
Purity:  98.05%
Target:  

PROTACs JAK

Research Areas:  

Cancer

SJ988497 is a PROTAC JAK2 degrader. SJ988497 potently inhibits CRLF2-rearranged (CRLF2r) cell proliferation and degrades the CRBN neosubstrate GSPT1. SJ988497 consists of a Ruxolitinib (HY-50856) derivative, linker, and CRBN ligand Pomalidomide. SJ988497 can be used in the research of acute lymphoblastic leukemia (ALL) .
loading...
    loading...
Cat. No.: HY-147330B
Purity:  97.66%
SJ1008030 (compound 8) formic is a JAK2 PROTAC which selectively degrades JAK2. SJ1008030 formic inhibits MHH–CALL-4 cell growth with an IC50 of 5.4 nM. SJ1008030 formic can be used for the research of leukemia .
loading...
    loading...
Cat. No.: HY-147330A
CAS No.: 2863634-97-1
Purity:  99.81%
Target:  

PROTACs JAK

Research Areas:  

Cancer

SJ1008030 (compound 8) TFA is a JAK2 PROTAC which selectively degrades JAK2. SJ1008030 TFA inhibits MHH–CALL-4 cell growth with an IC50 of 5.4 nM. SJ1008030 TFA can be used for the research of leukemia .
loading...
    loading...
Cat. No.: HY-147330
CAS No.: 2863634-96-0
Target:  

PROTACs JAK

Research Areas:  

Cancer

SJ1008030 (compound 8) is a JAK2 PROTAC which selectively degrades JAK2. SJ1008030 inhibits MHH–CALL-4 cell growth with an IC50 of 5.4 nM. SJ1008030 can be used for the research of leukemia .
loading...
    loading...